🇺🇸 US Stock Screener ← Switch market ⚡ HerAI

YCBD YCBD

Company Profile ↓
$0.46
-35.84% 1Y
Mkt Cap$4.10M
P/E-0.42
P/B0.69
52W High$2.27
52W Low$0.46
Book Value$0.81
EPS (TTM)$-1.09

Company Overview

YCBD (YCBD) is a publicly traded company listed on with a market capitalization of $4.10M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 32.4% CAGR over the past five years.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.11.

Recent Developments

  • Sep 2025 Revenue of $19.19M (-1.5% YoY); net profit $-2.04M.
  • Trailing 12 Months Year-on-year growth — revenue -1.5%.
  • 5-Year Trend Long-term compounding — revenue CAGR 32.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:32.41%
1 Year:-1.50%

Stock Price Performance

1 Year:-35.84%
6 Months:-36.11%
3 Months:-31.34%
1 Month:-7.26%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 0% of range
$0.46 $2.27
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)37.20 · Neutral
Price Performance
1M-7.26%
3M-31.34%
6M-36.11%
1Y-35.84%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 32.4% over 5 years.

CONS

  • Trading 79.7% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.42
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$0.81
Price to Book
0.69
P/S
0.26
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
32.41%
Profit 5Y
-
Revenue (YoY)
-1.50%
Earnings (YoY)
-

Profitability & Returns

ROCE
-29.93%
ROE
-28.24%
ROA
-19.59%
Profit Margin
-10.63%
Op Margin
-11.27%
Gross Margin
62.37%
EPS (Latest Qtr)
$-0.08
EPS (TTM)
$-1.09

Balance Sheet & Liquidity

Debt/Equity
0.11
Quick Ratio
1.20
Current Ratio
2.05
Debt
$778.24K
Total Assets
$12.25M
Current Assets
$8.38M
Working Capital
$3.36M

Ownership

Promoter Holding
10.00%
Chg in Prom Hold
-
FII / Inst Holding
8.19%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$4.10M
Total Revenue (TTM)
$19.19M
EBITDA
$-366.67K
Free Cash Flow
$-1.64M
Operating Cash Flow
$-1.45M
Shares Outstanding
8.92M
Gross Margin
62.37%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2016Mar 2017Jun 2017Dec 2017Mar 2018Jun 2018Dec 2018Mar 2019Jun 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 199.84K1.41M1.79M687.76K3.08M3.20M465.69K5.64M8.01M10.15M9.40M10.64M-12.33M11.80M10.56M-9.32M9.63M8.59M-6.09M6.24M6.12M-5.38M4.38M5.17M--4.75M4.61M4.72M5.02M5.64M
Cost of Revenue ------------------------------1.79M1.78M1.94M2.02M2.38M
Gross Profit 37.09K1.01M1.53M459.63K2.56M2.09M300.20K3.72M5.08M6.45M6.67M6.89M-8.90M8.16M7.19M-4.99M6.44M5.93M-3.57M4.02M3.85M-3.56M2.58M3.40M--2.96M2.83M2.78M3.00M3.26M
Operating Expenses ------------------------------3.45M3.74M3.46M3.29M4.06M
Operating Income -695.50K-211.31K-178.55K-1.30M1.62M627.25K-1.09M-2.03M-6.47M-6.11M-5.60M-1.34M--1.76M-4.17M-6.68M--25.15M-5.01M-33.13M--4.05M-1.40M-1.82M--1.07M-1.55M-382.03K---485.82K-904.69K-685.82K-286.29K-800.78K
EBITDA ------------------------------89.92K-456.17K-253.28K130.34K-378.05K
Interest Expense -----------------------------------
Pretax Income -------------------------------480.76K-895.27K-679.97K-283.13K-797.98K
Tax Provision -----------------------------------
Net Income -697.50K-288.20K-141.91K-1.26M1.64M565.25K-2.19M-31.85M-29.20M12.93M14.88M-8.95M-6.26M-9.40M-12.51M1.54M-2.92M-19.16M-4.66M-31.63M-14.63M-3.96M-1.34M-1.77M-15.87M-996.50K-3.01M459.74K-152.80K--480.76K-895.27K-679.97K-283.13K-797.98K
Diluted EPS --0.130.00-0.170.030.000.000.000.450.400.00--0.18-0.240.02--0.35-4.32-24.81--0.08-1.74-1.16---1.35-0.15--1.73-1.90-0.21--0.04-0.08

Profit & Loss (Annual)

Figures in USD.

Metric Sep 2016Sep 2017Sep 2018Sep 2019Sep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Revenue 2.03M4.47M459.09K23.65M41.88M-35.40M24.16M19.48M19.19M
Cost of Revenue ------13.07M9.18M7.49M7.22M
Gross Profit 413.13K3.12M355.08K14.51M26.37M-22.34M14.98M12.00M11.97M
Operating Expenses ------39.65M24.25M15.31M14.13M
Operating Income -3.89M-1.36M-1.80M-14.80M-17.58M--17.31M-9.27M-3.32M-2.16M
EBITDA -------14.34M-6.34M-1.49M-366.67K
Interest Expense -----28.93K----
Pretax Income -------70.08M-22.94M-3.70M-2.04M
Tax Provision ------0000
Net Income -3.90M-1.39M62.83K-51.36M12.60M--70.08M-22.94M-3.70M-2.04M
Diluted EPS --0.000.000.28--446.40-106.56-14.29-1.09

Balance Sheet (Annual)

Figures in USD.

Metric Sep 2015Sep 2016Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Sep 2025
Total Assets -1.62M7.07M---15.02M---94.52M---110.84M-------40.79M---16.20M---10.58M10.42M
Current Assets ----------------------16.01M---8.07M---6.39M6.55M
Cash & Equivalents 546.46K34.26K284.25K---4.28M---4.69M---14.82M-------6.72M---1.80M---2.45M2.26M
Inventory ----------------------4.26M---4.05M---2.37M2.73M
Receivables ----------------------1.45M---1.22M---983.91K1.04M
Total Liabilities -1.92M1.92M---998.46K---56.91M---31.66M-------9.37M---7.16M---8.62M3.19M
Current Liabilities -1.90M1.52M---969.96K---3.71M---7.69M-------5.29M---4.67M---8.62M3.19M
Long Term Debt --------------264.37K-----------------
Total Debt ----------------------4.87M---3.68M---1.27M778.24K
Total Equity 1.28M363.43K4.21M14.16M15.20M15.22M14.02M18.13M-13.45M25.15M37.60M55.52M92.16M83.58M79.18M85.72M85.88M89.28M-84.40M80.02M46.60M31.42M26.59M25.79M25.73M9.03M7.04M3.09M3.03M1.96M7.23M
Shares Outstanding ----------------------168.51K---370.07K---492.38K8.92M

Cash Flows (Annual)

Figures in USD.

Metric Sep 2016Sep 2017Sep 2018Sep 2019Sep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Operating Cash Flow -2.90M-2.33M-5.57M-15.38M-10.66M--14.97M-4.30M-352.79K-1.45M
Investing Cash Flow -127.26K192.03K-683.56K-2.13M-1.57M--688.68K702.45K-290.01K-184.17K
Financing Cash Flow 2.51M2.39M10.25M17.92M22.37M--4.04M-1.32M1.30M1.45M
Capital Expenditure -------688.68K-297.55K-290.01K-184.17K
Free Cash Flow -------15.66M-4.60M-642.81K-1.64M
Net Change in Cash -------19.69M-4.92M654.69K-191.31K
Dividends Paid ---0366.85K2.55M----

Ratios (Annual)

Figures in %.

Metric Sep 2016Sep 2017Sep 2018Sep 2019Sep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Gross Margin % 20.3%69.7%77.3%61.4%63.0%-63.1%62.0%61.6%62.4%
Operating Margin % -191.4%-30.4%-391.4%-62.6%-42.0%--48.9%-38.4%-17.0%-11.3%
Net Margin % -191.8%-31.0%13.7%-217.1%30.1%--198.0%-95.0%-19.0%-10.6%
ROE % -1,072.1%-32.9%0.4%-136.6%15.9%--223.0%-254.0%-188.5%-28.2%
ROCE % 1,385.1%-24.5%-12.8%-16.3%-17.0%--48.8%-80.4%-168.9%-29.9%

Shareholding Pattern

Insiders
10.00%
Institutions
8.19%
Public Float
9.10%

Top Institutional Holders

#Holder% HeldSharesValue
1 Worth Venture Partners, Llc 1.65% 184.80K $92.40K
2 CSS LLC 1.23% 137.62K $68.81K
3 Vanguard Capital Management LLC 1.07% 119.64K $59.82K
4 Chapin Davis, Inc. 0.73% 81.25K $40.62K
5 Chicago Partners Investment Group LLC 0.70% 78.10K $39.05K
6 Alesco Advisors, LLC 0.61% 68.51K $34.26K
7 Xtx Topco Ltd 0.56% 62.74K $31.37K
8 Jane Street Group, LLC 0.49% 54.40K $27.20K
9 Vanguard Fiduciary Trust Co 0.42% 47.16K $23.58K
10 UBS Group AG 0.19% 21.58K $10.79K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for YCBD

Yahoo Finance Wed, 02 Sep 2026

cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness

cbdMD, Inc. (NYSE American: YCBD), a leading consumer wellness company, today announced that it has entered into a definitive asset purchase agreement to acquire operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabol…

Yahoo Finance Mon, 10 Aug 2026

cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results

cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, August 13, 2026, to discuss the…

Yahoo Finance Fri, 24 Jul 2026

cbdMD Supports the Bipartisan Lawful Hemp Protection Act to Protect Consumers and Full-Spectrum CBD Access

cbdMD, Inc. (NYSE American: YCBD), a leader in hemp-derived wellness, today announced its support for the bipartisan Lawful Hemp Protection Act, introduced July 21 by Rep. Andy Barr (R-KY) and Rep. Angie Craig (D-MN). The legislation would …

Yahoo Finance ue, 14 Jul 2026

cbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina

cbdMD, Inc. (NYSE American: YCBD) today announced that its Oasis line of hemp-derived beverages is now available in South Carolina through a new distribution agreement with Morales Beverage Group, South Carolina, a leading beverage statewid…

Yahoo Finance ue, 07 Jul 2026

cbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination

cbdMD, Inc. (NYSE American: YCBD), one of the nation's most recognized and trusted hemp-derived wellness companies, today announced the completion of a self-affirmed Generally Recognized as Safe (GRAS) determination supporting the safe cons…

Yahoo Finance ue, 16 Jun 2026

cbdMD Appoints Wade Brown Chief Marketing Officer

cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most trusted cannabinoid wellness companies and operator of the cbdMD, Bluebird Botanicals, and Paw CBD brands, along with its THC beverage brand Oasis, today announced the …

YCBD — Frequently Asked Questions

What is the current share price of YCBD?

As of 2026-09-16 18:39 PDT, YCBD trades at $0.46 on NASDAQ/NYSE. Its 52-week range is $0.46 to $2.27.

What is the market capitalisation of YCBD?

YCBD has a market capitalisation of $4.10M on NASDAQ/NYSE.

What is the P/E ratio of YCBD?

YCBD trades at a trailing price-to-earnings (P/E) ratio of -0.42. Its price-to-book (P/B) ratio is 0.69.

What is the return on equity (ROE) of YCBD?

YCBD has a return on equity (ROE) of -28.24%. Its return on capital employed (ROCE) is -29.93%.

Is YCBD a good stock to buy?

This page provides a data-driven analysis of YCBD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space